Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$4.68
-2.7%
$4.57
$3.42
$9.35
$263.08M1.632.00 million shs578,847 shs
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
$1.48
$1.45
$0.63
$1.51
$60.83M1.25570,387 shsN/A
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
$24.57
-3.2%
$24.18
$6.20
$29.27
$270.74M0.169,452 shs43,813 shs
ZYBT
Zhengye Biotechnology
$14.15
+35.5%
$5.59
$3.50
$14.25
$667.40MN/A275,651 shs366,033 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.00%+8.33%+8.58%+29.30%-28.21%
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
0.00%0.00%0.00%+29.82%+94.74%
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
0.00%+4.23%-9.64%+96.82%+2,538,999,900.00%
ZYBT
Zhengye Biotechnology
0.00%+3.78%+104.31%+132.52%+1,043,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.5193 of 5 stars
0.02.00.00.02.60.80.6
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
3.4233 of 5 stars
4.60.00.00.02.72.50.6
ZYBT
Zhengye Biotechnology
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
3.67
Strong BuyN/AN/A
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
0.00
N/AN/AN/A
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
3.13
Buy$44.4380.82% Upside
ZYBT
Zhengye Biotechnology
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ACHL, ZYBT, PVLA, and ACB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/9/2025
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$50.00
4/1/2025
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$38.00 ➝ $38.00
3/26/2025
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$45.00
3/25/2025
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
Jones Trading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$45.00
3/24/2025
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
Jones Trading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
3/7/2025
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Outperform$50.00
2/26/2025
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$39.00 ➝ $39.00
2/20/2025
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$39.00
2/11/2025
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$38.00 ➝ $38.00
2/5/2025
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
Atb Cap Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
2/5/2025
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$44.00
(Data available from 4/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$320.81M0.82$0.18 per share26.35$8.18 per share0.57
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
N/AN/AN/AN/A$3.49 per shareN/A
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
$42.81M6.32N/AN/A$21.66 per share1.13
ZYBT
Zhengye Biotechnology
$189.75M3.52N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$48.62M$0.0593.6210.64N/A0.42%0.59%0.42%6/19/2025 (Estimated)
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
-$69.67M-$1.65N/AN/AN/AN/A-54.45%-47.68%5/6/2025 (Estimated)
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
-$24.54M-$12.10N/AN/AN/AN/A-80.93%-59.55%5/13/2025 (Estimated)
ZYBT
Zhengye Biotechnology
N/AN/A0.00N/AN/AN/AN/AN/A

Latest ACHL, ZYBT, PVLA, and ACB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/21/2025Q1 2025
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
-$3.40N/AN/AN/AN/AN/A
2/5/2025Q3 2025
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$0.09$0.06+$0.15$0.41$80.01 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
N/AN/AN/AN/AN/A
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
N/AN/AN/AN/AN/A
ZYBT
Zhengye Biotechnology
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.07
3.30
1.60
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
N/A
6.04
6.04
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
N/A
4.82
4.82
ZYBT
Zhengye Biotechnology
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
47.63%
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
56.38%
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
40.11%
ZYBT
Zhengye Biotechnology
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,34056.21 million54.85 millionOptionable
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
25041.10 million38.89 millionNot Optionable
Palvella Therapeutics stock logo
PVLA
Palvella Therapeutics
N/A11.02 million10.50 millionN/A
ZYBT
Zhengye Biotechnology
27847.17 millionN/AN/A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aurora Cannabis stock logo

Aurora Cannabis NASDAQ:ACB

$4.68 -0.13 (-2.70%)
Closing price 04:00 PM Eastern
Extended Trading
$4.70 +0.02 (+0.43%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Achilles Therapeutics stock logo

Achilles Therapeutics NASDAQ:ACHL

$1.48 0.00 (0.00%)
As of 03/26/2025

Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The company offers PELEUS, a proprietary AI-powered bioinformatics platform, used to identify clonal neoantigens in a patient. It also develops CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.

Palvella Therapeutics stock logo

Palvella Therapeutics NASDAQ:PVLA

$24.57 -0.82 (-3.23%)
As of 04:00 PM Eastern

Palvella Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. Palvella Therapeutics Inc., formerly known as Pieris Pharmaceuticals Inc., is based in WAYNE, Pa.

Zhengye Biotechnology NASDAQ:ZYBT

$14.15 +3.71 (+35.54%)
As of 04:00 PM Eastern

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.